[1]JournalofMedicinalChemistry,1989,vol.32,p.2204-2210
[2]Patent:EP1422228,2004,A1.Locationinpatent:Page195
[1]CurrentPatentAssignee:LAVALUNIVERSITY-WO2010/132999,2010,A1Locationinpatent:Page/Pagecolumn178-179
1227268-77-0
1216294-32-4
178488-39-6
178488-40-9
30489-43-1
6200-60-8
30595-57-4 | Hydrazine, (2,4-dichlorophenethyl)-, sulfate (1:1) (8CI) | AA0030K1 | MFCD08457084
306935-93-3 | 2,4-Di(tert-butoxy)pyrimidin-5-ylboronic acid hydrate | AA0030TA | MFCD02180675
307307-84-2 | Ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-2-carboxylate | AA00310C | MFCD11975790
308386-35-8 | tert-butyl 4-(pyridin-4-yloxy)piperidine-1-carboxylate | AA0031DJ | MFCD09261175
30979-48-7 | 1-Imidazolidinecarboxamide, N-(2-methylpropyl)-2-oxo- | AA0031QK | MFCD00055504
310880-25-2 | 3-(2-Aminoethoxy)pyridine | AA003209 | MFCD12192564
35011-47-3 | 2,5,6-Triaminopyrimidin-4(3h)-one sulfate | AA003267 | MFCD00012785
352534-88-4 | 2-Butoxy-5-chlorophenylboronic acid | AA00329B | MFCD08276746
309956-78-3 | (R)-3-Boc-aminopiperidine | AA0032C9 | MFCD03093382
877399-74-1 | 1-(1-Boc-4-piperidyl)pyrazole-4-boronic acid pinacol ester | AA0032FG | MFCD11112131